Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Feb 28, 2025
Medical Companies Segment Shows Strong Performance with +3.53% Weekly Growth

Medical Companies Segment Shows Strong Performance with +3.53% Weekly Growth

The medical companies segment has experienced a notable increase in performance, recording a weekly gain of +3.53%. This sector encompasses companies involved in the production and supply of pharmaceuticals and essential medical products, catering to a broad spectrum of healthcare needs. Their product offerings include surgical apparel, gloves, hospital furniture, fluid management solutions, and specialized equipment for cosmetic and surgical procedures. Key players within this sector include Cardinal Health, Hill-Rom Holdings, and Apyx Medical, each contributing to this segment’s impressive growth trajectory.

Market Capitalization in the Medical Segment

The average market capitalization across this group of medical companies stands at an impressive $26.8 billion. The companies within this segment vary widely in size, with market capitalizations ranging from $2.7 billion to a high of $53.2 billion. Welltower Inc. (WELL) is the largest player in the group, with a valuation of $53.2 billion, while Inari Medical (NARI) has the smallest market cap, standing at $2.7 billion. This diversity in market cap reflects the varying scales of companies in the sector, from large established firms to more specialized, smaller enterprises.

Price Growth Analysis

Over the past week, the average price growth across the segment’s stocks was 3.53%. When observed over a monthly period, the price growth averaged out at 0.7%, while the quarterly price growth demonstrated a more substantial increase of 15.09%. The weekly growth highlights some notable outperformers within the group:

  • Molina Healthcare (MOH): This stock showed an outstanding weekly price growth of +11.79%.
  • Cardinal Health (CAH): CAH also had a positive week, recording a +6.69% increase in price, reaching $103.39.
  • Inari Medical (NARI): NARI experienced a significant price jump of +9.15%, reflecting strong investor interest.

Conversely, Cardinal Health, despite being among the weekly gainers, did have a minimal fall of 0.21% over a longer monthly period, signaling some volatility within the broader uptrend.

Notable Price Movement Announcements

  • August 2, 2024: Cardinal Health (CAH) marked a +6.69% weekly price increase, solidifying its position as a top gainer in the segment.
  • July 26, 2024: Molina Healthcare (MOH) posted an impressive weekly gain of +12.66%, reflecting strong investor confidence.
  • July 2, 2024: Inari Medical (NARI) also achieved a +9.15% weekly gain, further bolstering the overall segment's performance.

Volume Trends in the Medical Segment

Examining volume trends offers additional insight into investor activity within this sector. The average weekly volume growth across the segment declined by -11.53%, indicating some moderation in trading activity. However, this trend changes over a longer timeframe, with the average monthly volume growth surging by 104.57% and quarterly volume growth increasing by 59.5%. This spike in volume over the past quarter suggests heightened investor interest, potentially driven by favorable developments or an optimistic outlook for the sector.

Key Volume Movement Announcements:

  • September 21, 2024: Welltower Inc. (WELL) saw a remarkable single-day volume increase, hitting 215% of its 65-day volume moving average.
  • June 1, 2024: Molina Healthcare (MOH) experienced three consecutive days of elevated trading volume, achieving a peak of 226% above its 65-day volume moving average.
  • March 29, 2024: Inari Medical (NARI) had an impressive surge in trading volume, reaching 824% above its 65-day volume moving average for a single day.

These substantial increases in volume may suggest significant investor actions, such as institutional buys or elevated market interest following major announcements or earnings reports.

Technical Indicators: Positive Momentum and Buy Signals

Several technical indicators suggest potential upward movement in key stocks within the segment, providing signals for potential buying opportunities.

          1. Molina Healthcare (MOH) Breaks Lower Bollinger Band

On October 17, 2024, Molina Healthcare's stock dipped below its lower Bollinger Band, a technical indicator that often signals an upward correction. Historically, in 27 out of 32 instances when MOH's price broke its lower Bollinger Band, the stock price rose in the following month. With an 84% probability of an upward trend, this pattern suggests that MOH may see positive price action soon, potentially making it an attractive candidate for traders considering buying the stock or exploring call options.

          2. Momentum Indicator Turns Positive for Welltower (WELL)

Welltower's Momentum Indicator moved above zero on October 15, 2024, signaling a possible new upward trend. This shift in momentum is typically an early indicator of positive price movement. Analyzing 86 previous instances where this indicator turned positive, the stock rose in 60 cases, giving a 70% likelihood of continued upward movement. Investors may see this as an opportunity to buy WELL shares or purchase call options, riding the potential bullish momentum.

          3. Stochastic Oscillator Signals Potential Decline for Inari Medical (NARI)

On October 18, 2024, the Stochastic Oscillator for Inari Medical moved out of the overbought zone, signaling a possible bearish outlook. Historical data suggests that in 43 out of 54 similar instances, NARI's stock price declined following the exit from the overbought zone, indicating an 80% chance of a downward trend. This technical signal may prompt investors to adopt a defensive stance or consider selling NARI, as there’s a high probability of a short-term pullback.

Summary

The medical companies segment has shown robust performance, with an average weekly price gain of +3.53% and significant quarterly price growth of 15.09%. Companies within this sector, such as Cardinal Health, Molina Healthcare, and Inari Medical, have been at the forefront of this growth, benefiting from strong demand for medical supplies and healthcare services. As investors analyze this sector, they are likely to consider both price and volume trends, along with technical indicators, to identify optimal entry and exit points for these stocks.

Molina Healthcare and Welltower currently exhibit positive momentum signals, suggesting potential buy opportunities, while Inari Medical’s technical indicators signal a possible retracement. With an average market capitalization of $26.8 billion and high trading volumes, this segment presents a dynamic environment for investors looking to gain exposure to the medical supply and healthcare industry.

Related Ticker: NARI, MOH, CAH, WELL

Contributor

Dem Sem's AvatarDem Sem|Expert

View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a medical device company which develops, manufactures, markets and sells devices for the interventional treatment of venous diseases

Industry MedicalSpecialties

Profile
Details
Industry
N/A
Address
6001 Oak Canyon
Phone
+1 877 923-4747
Employees
1300
Web
https://www.inarimedical.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.